Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kuipers

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Plos One|May 30, 2013
Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic statusHamid Aslami, Wilco P Pulskens, Maria T Kuipers, et al.
Anesthesiology|April 26, 2012
Ventilator-induced lung injury is mediated by the NLRP3 inflammasomeMaria T Kuipers, Hamid Aslami, John R Janczy, et al.
JCO Oncology Practice|December 12, 2022
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy ToxicitiesAnne M Spanjaart, Elise R A Pennings, Milan Kos, et al.
Blood Advances|August 28, 2023
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapyJanneke W de Boer, Elise R A Pennings, Ankie Kleinjan, et al.
Blood Advances|December 5, 2023
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementationKristine A Frerichs, Christie P M Verkleij, Maria Victoria Mateos, et al.
Blood Advances|July 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections and survival after CART in R/R LBCLJanneke W. de Boer, Kylie Keijzer, Suzanne van Dorp, et al.
Cancers|September 9, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The NetherlandsAnne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Plos One|May 30, 2013
Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic statusHamid Aslami, Wilco P Pulskens, Maria T Kuipers, et al.
Anesthesiology|April 26, 2012
Ventilator-induced lung injury is mediated by the NLRP3 inflammasomeMaria T Kuipers, Hamid Aslami, John R Janczy, et al.
JCO Oncology Practice|December 12, 2022
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy ToxicitiesAnne M Spanjaart, Elise R A Pennings, Milan Kos, et al.
Blood Advances|August 28, 2023
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapyJanneke W de Boer, Elise R A Pennings, Ankie Kleinjan, et al.
Blood Advances|December 5, 2023
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementationKristine A Frerichs, Christie P M Verkleij, Maria Victoria Mateos, et al.
Blood Advances|July 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections and survival after CART in R/R LBCLJanneke W. de Boer, Kylie Keijzer, Suzanne van Dorp, et al.
Cancers|September 9, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The NetherlandsAnne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, et al.
Pageof 7